SUWANEE, GA--(Marketwired - Sep 25, 2017) - SANUWAVE Health, Inc. (
Shareholders and other interested parties can participate in the conference call by dialing 866-682-6100 (U.S.) or 404-267-0373 (International) or via webcast at http://www.investorcalendar.com/event/20309.
A replay of the conference call will be available beginning two hours after its completion through December 27, 2017, by dialing 877-481-4010 (U.S.) or 919-882-2331 (International) and entering Conference ID 20309.
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. (
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company's product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company's ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
For additional information about the Company, visit www.sanuwave.com.